Zonisamide add-on for drug-resistant partial epilepsy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2013-12-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD001416.pub3PMID 24353187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of Adjunctive Zonisamide in Adult Patients with Refractory Partial-Onset Epilepsy

  2011cited by this paper
• Chapter 8: Assessing risk of bias in included studies

  2008cited by this paper
• Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.

  2007cited by this paper
• The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

  2007cited by this paper
• Zonisamide as adjunctive therapy for refractory partial seizures.

  2006cited by this paper
• Dose‐dependent Safety and Efficacy of Zonisamide: A Randomized, Double‐blind, Placebo‐controlled Study in Patients with Refractory Partial Seizures

  2005cited by this paper
• Zonisamide add-on for drug-resistant partial epilepsy.

  2005cited by this paper
• Best Practice Guidelines for the Management of Women with Epilepsy

  2005cited by this paper
• Abnormal Phonologic Processing in Familial Lateral Temporal Lobe Epilepsy Due to a New LGI1 Mutation

  2005cited by this paper
• Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial Seizures

  2004cited by this paper
• Zonisamide: chemistry, mechanism of action, and pharmacokinetics.

  2004influential reference
• Resective Surgery for Intractable Focal Epilepsy in Patients with Low IQ: Predictors for Seizure Control and Outcome with Respect to Seizures and Neuropsychological and Psychosocial Functioning

  2004cited by this paper
• Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures.

  2003cited by this paper
• Zonisamide add-on for drug-resistant partial epilepsy.

  2002cited by this paper
• Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

  2001cited by this paper
• Carbamazepine versus valproate monotherapy for epilepsy.

  2000cited by this paper
• The anticonvulsant zonisamide scavenges free radicals.

  1998cited by this paper
• The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability

  1997cited by this paper
• New antiepileptic drugs: a systematic review of their efficacy and tolerability

  1996cited by this paper
• Epidemiology of the epilepsies.

  1996cited by this paper
• Remission of epilepsy: results from the National General Practice Study of Epilepsy.

  1995cited by this paper
• Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984

  1993cited by this paper
• Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

  1993cited by this paper
• Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex.

  1992cited by this paper
• The Antiepileptic Effect of Zonisamide on Patients with Refractory Seizures and Its Side Effect

  1988cited by this paper

• Psychiatric and behavioural side effects of antiseizure medications in epilepsy

  2025cites this paper
• Overview of Movement Disorders Secondary to Drugs

  2023cites this paper
• Antiseizure Medication Therapy

  2021cites this paper
• Guideline

  2020cites this paper
• The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations.

  2020cites this paper
• The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection

  2019cites this paper
• Zonisamide add-on therapy for focal epilepsy.

  2018cites this paper
• Comparison of levetiracetam or zonicamide additional treatments in partial epilepsy diseases which karbamazepine monotherapy is not responded

  2018cites this paper
• Zonisamide add-on therapy for focal epilepsy.

  2018cites this paper
• Effect of topiramate and zonisamide on fMRI cognitive networks

  2017cites this paper
• Outcome of treatment changes in patients with drug-resistant chronic epilepsy: A tertiary center experience.

  2017cites this paper
• Pharmacotherapy for cavernous malformations.

  2017cites this paper
• Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review

  2016cites this paper
• “<<AED generic name>> AND (anger OR aggression OR irritability OR hostility OR impulsivity OR homicide OR homicidality OR agitation OR assault)”

  2016cites this paper
• Brivaracetam add-on for refractory focal epilepsy

  2016cites this paper
• Emerging drugs for partial-onset epilepsy: a review of brivaracetam

  2016cites this paper
• Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?

  2016cites this paper
• The effects of genes, antiepileptic drugs and risk of death on functional anatomy and cognitive networks in epilepsy

  2016cites this paper
• Antiepileptic Drugs: Second and Third Generation

  2015cites this paper
• Antiepileptic Drug Treatment in Children with Epilepsy

  2015influential citation
• T-type calcium channel blockers as neuroprotective agents

  2014cites this paper
• Pharmacotherapy of focal epilepsy

  2014cites this paper
• Zonisamide as a Treatment for Partial Epileptic Seizures: A Systematic Review

  2014cites this paper
• Применение зонисамида (Зонегран) в лечении эпилепсии: акцент на монотерапию фокальных приступов (обзор зарубежной литературы)

  2014cites this paper
• Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective

  2014cites this paper
• Zonisamide: A Review of Its Use in the Management of Adults with Partial Seizures

  2013cites this paper
• Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults

  2013cites this paper
• Actualización de las guías para el tratamiento farmacológico de la epilepsia en adultos

  2013cites this paper
• Perampanel: What is its Place in the Management of Partial Onset Epilepsy?

  2013cites this paper
• The adverse event profile of lacosamide: A systematic review and meta‐analysis of randomized controlled trials

  2013cites this paper
• Management of Focal-Onset Seizures

  2012cites this paper
• The adverse event profile of pregabalin across different disorders: a meta-analysis

  2012cites this paper
• A Practitioner’s Guide to Prescribing Zonisamide for Adults with Intellectual Disabilities

  2012cites this paper
• Zonisamide in Parkinson’s Disease: An Evidence-Based Review of its Impact on Clinical Outcomes

  2012cites this paper
• Role of Cochrane reviews in pediatric neurology.

  2012cites this paper
• Zonisamide: its pharmacology, efficacy and safety in clinical trials

  2012cites this paper
• 7 Zonisamide – An Overview

  2012cites this paper
• Zonisamide – An Overview

  2011cites this paper
• Review of Therapeutic Options for Adjuvant Treatment of Focal Seizures in Epilepsy

  2011cites this paper
• The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trials

  2011cites this paper
• Zonisamide in the treatment of epilepsy

  2011cites this paper
• Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta‐analysis

  2011cites this paper
• Adult Epilepsy: Cascino/Adult Epilepsy

  2011cites this paper
• Drug safety evaluation of zonisamide for the treatment of epilepsy

  2011cites this paper
• Tratamiento de la epilepsia

  2011cites this paper